河北医学
河北醫學
하북의학
HEBEI MEDICINE
2015年
1期
3-6
,共4页
宫颈癌%B23%Ki67%预后
宮頸癌%B23%Ki67%預後
궁경암%B23%Ki67%예후
Cervical neoplasm%B23%Ki67%Prognosis
目的:探讨B23和Ki67与宫颈癌预后的关系。方法:免疫组织化学染色检测104例宫颈癌及20例正常宫颈组织中B23和Ki67的表达水平,统计学分析宫颈癌患者生存率与B23和Ki67的表达水平的关系。结果:B23在正常宫颈组织和宫颈癌组织中的阳性率分别为30.0%和76.9%( P<0.001)。 Ki67在正常宫颈组织和宫颈癌组织中阳性率分别为15.0%和44.2%( P=0.014)。单因素分析显示B23及Ki67的表达与宫颈癌的无进展生存率呈负相关。 B23和Ki67的表达存在正相关关系( P<0.05)。结论:联合检测B23和Ki67可能有助于判断宫颈癌的生存率,作为临床疗效的预后指标。
目的:探討B23和Ki67與宮頸癌預後的關繫。方法:免疫組織化學染色檢測104例宮頸癌及20例正常宮頸組織中B23和Ki67的錶達水平,統計學分析宮頸癌患者生存率與B23和Ki67的錶達水平的關繫。結果:B23在正常宮頸組織和宮頸癌組織中的暘性率分彆為30.0%和76.9%( P<0.001)。 Ki67在正常宮頸組織和宮頸癌組織中暘性率分彆為15.0%和44.2%( P=0.014)。單因素分析顯示B23及Ki67的錶達與宮頸癌的無進展生存率呈負相關。 B23和Ki67的錶達存在正相關關繫( P<0.05)。結論:聯閤檢測B23和Ki67可能有助于判斷宮頸癌的生存率,作為臨床療效的預後指標。
목적:탐토B23화Ki67여궁경암예후적관계。방법:면역조직화학염색검측104례궁경암급20례정상궁경조직중B23화Ki67적표체수평,통계학분석궁경암환자생존솔여B23화Ki67적표체수평적관계。결과:B23재정상궁경조직화궁경암조직중적양성솔분별위30.0%화76.9%( P<0.001)。 Ki67재정상궁경조직화궁경암조직중양성솔분별위15.0%화44.2%( P=0.014)。단인소분석현시B23급Ki67적표체여궁경암적무진전생존솔정부상관。 B23화Ki67적표체존재정상관관계( P<0.05)。결론:연합검측B23화Ki67가능유조우판단궁경암적생존솔,작위림상료효적예후지표。
Objective: To study the expressions of B 23 and Ki67 in cervical carcinoma and evaluate their roles in progonosis .Method:Tissues from 104 cervical carcinoma and 20 normal cervices were obtained with analysis of B 23 and Ki67 expressions by immunohistochemistry .Result:The positive expression rate of B23 in normal cervix and cervical carcinoma was 30.0%and 76.9%respectively (P<0.001), and the posi-tive expression rate of Ki67 in normal cervix and cervical carcinoma was 15.0%and 44.2%respectively (P=0.014).The expressions of B23 and Ki67 were all negatively correlated with progressive-free survial rate of cervical carcinoma .The expression of B 23 was positively correlated with Ki 67 expression .Conclusion: The expression of Ki67 is a significant unfavorable factor of prognosis of cervical squamous cell carcinoma .Com-bined analysis of expressions of B 23 and Ki67 maybe helpful to judge prognosis of cervical carcinoma , and can be a reference factor of the clinical therapy .